The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
The INFLUENTIAL Trial - Inpatient FLU Vaccination Program Effectiveness: National Trial Implementing Best Practices and Learning Collaboratives
Who can join
6 Months – 99 Years · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * At least 6 months of age * Admitted to an inpatient unit at a participating health system Exclusion: \- Admission to critical care sites or hematology-oncology services Exclusion Criteria: * At least 6 months of age * Admitted to an inpatient unit at a participating health system Exclusion: \- Admission to critical care sites or hematology-oncology services
About the study
This study plans to learn more about whether a stakeholder-informed, standardized inpatient vaccination program will increase influenza vaccination rates of hospitalized children across US pediatric health systems. The first part of the study is to form a multidisciplinary team of stakeholders, including parents, providers, nurses, pharmacists, informaticists, data analysts and communication experts across three sites in synthesizing a best practice implementation guide for an inpatient influenza vaccination program, which will then be piloted at these three sites.
What is being tested
- Existing Influenza Vaccination Practices (other)
- Standardized inpatient influenza vaccination program (other)
Sponsor: University of Colorado, Denver · Participants: 22,000 · Started: Oct 31, 2024
Contact the study team
- Suchitra Rao · Phone: 7207772823
Official record on ClinicalTrials.gov — NCT05832307
Locations in the U.S.
| Illinois | Ann and Robert Lurie's Children Hospital of Chicago, Chicago |
| Washington | Seattle Children's Hospital, Seattle |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.